BridgeBio to Participate in May and June Investor Conferences
Rhea-AI Summary
BridgeBio (Nasdaq: BBIO) announced management will participate in investor fireside chats at three healthcare conferences in May–June 2026: BofA Health Care Conference (May 12, 2:20 pm PDT), Jefferies Global Healthcare Conference (June 4, 11:05 am EDT), and Goldman Sachs Global Healthcare Conference (June 9, 8:00 am EDT).
Live webcasts will be available via the company’s Events and Presentations investor page and replays will remain online for 90 days after each event.
Details
News Market Reaction – BBIO
On May 7, the first trading day after this news, BBIO closed 0.94% below the previous close.
Data tracked by StockTitan Argus for the May 7 session.
Key Figures
- BofA conference time
- 2:20 pm PDT
- BofA Securities Health Care Conference 2026 fireside chat on May 12, 2026
- Jefferies conference time
- 11:05 am EDT
- Jefferies Global Healthcare Conference fireside chat on June 4, 2026
- Goldman Sachs conference time
- 8:00 am EDT
- Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026
- Webcast replay window
- 90 days
- Replay of the conference webcasts available on BridgeBio’s website
- Current price
- $68.78
- Price prior to the conference participation announcement
- 52-week high
- $84.94
- Upper end of 52-week trading range before this news
- 52-week low
- $31.77
- Lower end of 52-week trading range before this news
- Market capitalization
- $13,374,599,470
- Equity value at latest pre-announcement price
Historical Context
-
New Phase 3 ATTRibute-CM data presentations at ESC-Heart Failure 2026.
-
Announcement of date and time for Q1 2026 results and webcast.
-
Launch of national ATTR-CM health education campaign featuring high-profile advocates.
-
Inducement grants of 67,247 RSUs to new employees under existing plan.
-
Long-term acoramidis data showing large mortality reductions and sustained benefit.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PALO ALTO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, today announced that members of its management team will participate in fireside chats at the following healthcare investor conferences:
- BofA Securities Health Care Conference 2026, Las Vegas, NV: Tuesday, May 12 at 2:20 pm PDT
- 2026 Jefferies Global Healthcare Conference, New York, NY: Thursday, June 4 at 11:05 am EDT
- Goldman Sachs 47th Annual Global Healthcare Conference, Miami FL: Tuesday, June 9 at 8:00 am EDT
To access the live webcast of BridgeBio’s presentations, please visit the “Events and Presentations” page within the Investors section of the BridgeBio website at https://investor.bridgebio.com. A replay of the webcasts will be available on the BridgeBio website for 90 days following the event.
About BridgeBio Pharma, Inc.
BridgeBio exists to develop transformative medicines for genetic conditions. Millions of people worldwide living with genetic conditions lack treatment options, often because drug development for small patient populations can be commercially challenging. We aim to bridge the gap between advancements in genetic science and meaningful medicines for underserved patient populations. Our decentralized, hub-and-spoke model is designed for speed, precision, and scalability. Autonomous and empowered teams focus on individual conditions, while a central hub provides the clinical, regulatory, and commercial capabilities needed to bring innovation to market. For more information, visit bridgebio.com and follow us on LinkedIn, X, Facebook, Instagram, YouTube, and TikTok.
BridgeBio Media Contact:
Bubba Murarka, Executive Vice President
contact@bridgebio.com
(650)-789-8220
BridgeBio Investor Contact:
Chinmay Shukla, Senior Vice President, Strategic Finance
ir@bridgebio.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.